Fibronectin, TGF-β1 protein, and hydroxyproline were measured in the drug-sensitive and -resistant cancer cell lines following curcumin treatment at doses of 2.7 and 54.3 μM, Figure 5. The gene discussed is TGFB1; the disease is cancer.